• Return to Headlines

Shares of Aimmune Therapeu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (AIMT , CHRS , HRTX , KPTI , CARA )

By David Diaz

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Aimmune Therapeu (NASDAQ:AIMT ) ranks first with a gain of 11.82%; Coherus Bioscien (NASDAQ:CHRS ) ranks second with a gain of 5.79%; and Heron Therapeuti (NASDAQ:HRTX ) ranks third with a gain of 5.64%.

Karyopharm Thera (NASDAQ:KPTI ) follows with a gain of 5.42% and Cara Therapeutic (NASDAQ:CARA ) rounds out the top five with a gain of 3.80%.

SmarTrend recommended that subscribers consider buying shares of Karyopharm Thera on March 20th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $5.36. Since that recommendation, shares of Karyopharm Thera have risen 72.2%. We continue to monitor Karyopharm Thera for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance aimmune therapeu coherus bioscien heron therapeuti karyopharm thera cara therapeutic

Ticker(s): AIMT CHRS HRTX KPTI CARA